Popular Articles
Stretch Mark

Encouraging Heart Failure Patients To Enjoy Their Food -- Even If It's Not As Salty As Before
The individualised management programme of France"s "Réseau Respecti-coeur" makes quality of life the first objective for heart failure patients, and one of the network"s dieticians, Mme Hélène Guibert, explained that the heart-healthy eating recommended in the programme need not be a of frustration or misery - even for a Frenchman. "For many old people," she told Heart Failure Congress 2009, "meals are important occasions, and it"s our aim to bring together at these times health and pleasure."1,2
generic viagra online
Sports & Orthopaedic Specialists Launch Program To Prevent ACL Injury And Enhance Performance
Sports & Orthopaedic Specialists, a national leader in orthopedic care for women, in collaboration with Sister Kenny Sports and Physical Therapy, launched the renowned Prevent Injury and Enhance Performance (PEP) program to the local and regional market. PEP is an exercise and training program designed to significantly reduce the incidence of ACL injury and enhance performance as an added benefit.
News of the day
In Prostate Cancer, Gene Activity Reveals Dynamic Stroma Microenvironment
As stroma - the supportive framework of the prostate gland- react to prostate cancer, changes in the expression of genes occur that induce the formation of new structures such as blood vessels, nerves and parts of nerves, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Clinical Cancer Research.
Cardiovascular

House Panel Passes Protection For Drug Makers

The House Energy and Commerce Committee passed an amendment to their broad health reform bill giving drug makers 12 years of exclusive rights to market new biologic drugs, "a setback" to the administration and consumer advocates who hoped to make generic drugs more widely available, the Wall Street Journal reports. The panel voted 47-11 on the measure, which "would also allow "evergreening," the practice by pharmaceutical companies of making minimal adjustments to their drugs, such as creating extended-release versions, as a way to lengthen their monopoly." "Mr. Obama and some Democrats, including the energy committee chairman, Rep. Henry Waxman, D-Calif., have pushed for getting generic versions of complex biologic drugs to the market in five to seven years, saying it would speed up access for consumers to cheaper generic brands and help reduce the country"s health-care costs," the Journal reports (Mundy, 8/1). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):